FRANK SAVIANO: Open Payments
NPI 1760971626 · OCEANSIDE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 24 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $220 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $107 |
| Lilly USA, LLC | 3 | $61 |
| Novo Nordisk Inc | 3 | $55 |
| ABBVIE INC. | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Amgen Inc. | 2 | $38 |
| MEDICOMP INC | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Exact Sciences Corporation | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: XIFAXAN, REXULTI, MOUNJARO, OTEZLA, Ozempic, TELEPATCH CARDIAC MONITOR, VRAYLAR, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
